Merck pays Moderna $250m for joint development of skin cancer vaccine
Moderna’s mRNA vaccine is being studied in combination with Merck’s Keytruda to treat patients with high-risk melanoma
Drugs
Pharma
Drugs
Medical
Pharma
Neumora Therapeutics raises $112 million in series B to fund neuro disorder research
Neumora Therapeutics raises $650 million to date to revolutionize treatment of brain diseases
Health
Uncategorized
Liver cancer deaths may increase by 55% in another 20 years
Liver cancer deaths set to increase by 50 percent by 2040; study
Drugs
Pharma
Stalicla signs license deal for Evgens’ SFX-01
Evgen Pharma and Stalicla sign a $165 million licensing deal for neuro development disorder SFX-01 asset
Drugs
Pharma
Merck’s Covid-19 pill fails initial trial; AstraZenaca’s nasal spray too ineffective
Merck's Covid-19 pill no help in reducing hospitalization or death, Astrazenaca's nasal spray too fails trial
Pharma
Marksans Pharma to acquire Israel’s Tevapharm’s site in Goa
HQ team October 12, 2022: Marksans Pharma, a listed company, is set to acquire a manufacturing site of Tevapharm, an Indian subsidiary of.
Pharma
Cipla joins WEF’s ‘Lighthouse network’ to digitally transform operations
Cipla, an Indian pharmaceutical company, has joined the World Economic Forum’s Lighthouse network to adopt advanced fourth-industrial revolution technologies to transform operations digitally.
Health
Medical
AI will soon diagnose illnesses based on speech patterns
AI based speech reading to diagnose certain illnesses on the way
Drugs
Health
Medical
New malaria vaccine brings hope to millions in Africa
New malaria vaccine by Oxford University has 80% efficacy
Climate
Health
Half of global poor need urgent debt relief: UNDP
HT team October 11, 2022: More than half of the world’s poorest people, living in 54 developing economies, need urgent debt relief due.